SYRE
Spyre Therapeutics Inc.
$69.67
+$0.43(+0.62%)
52
Overall
60
Value
75
Tech
23
Quality
Market Cap
$1.65B
Volume
601.09K
52W Range
$12.29 - $75.00
Target Price
$90.13
Key Metrics Overview
| Market Cap | $1.65B | P/E Ratio | N/A |
| 52W High | $75.00 | 52W Low | $12.29 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 56.9% | 52W Position | 91.5% |
| Overall Score | 52 | Value Score | 60 |
| Quality Score | 23 | Technical Score | 75 |
Growth Analysis
| EPS Current Est | $-2.8 | EPS Next Est | $-2.88 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $69.67 | +0.6% | 601.09K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |